Paratek Pharmaceuticals Stock Filter Stocks by Fundamentals
PRTKDelisted Stock | USD 2.18 0.00 0.00% |
Paratek Pharmaceuticals fundamentals help investors to digest information that contributes to Paratek Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Paratek Stock. The fundamental analysis module provides a way to measure Paratek Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Paratek Pharmaceuticals stock.
Paratek |
Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Paratek Fundamentals
Return On Asset | -0.18 | |||
Profit Margin | (0.35) % | |||
Operating Margin | (0.25) % | |||
Current Valuation | 345.3 M | |||
Shares Outstanding | 57.32 M | |||
Shares Owned By Insiders | 11.70 % | |||
Shares Owned By Institutions | 55.08 % | |||
Number Of Shares Shorted | 2.64 M | |||
Price To Earning | (5.49) X | |||
Price To Sales | 0.86 X | |||
Revenue | 150.79 M | |||
Gross Profit | 99.39 M | |||
EBITDA | (44.9 M) | |||
Net Income | (63.57 M) | |||
Cash And Equivalents | 57.01 M | |||
Cash Per Share | 1.03 X | |||
Total Debt | 258.41 M | |||
Debt To Equity | 3.20 % | |||
Current Ratio | 3.11 X | |||
Book Value Per Share | (3.52) X | |||
Cash Flow From Operations | (66.14 M) | |||
Short Ratio | 6.74 X | |||
Earnings Per Share | (1.11) X | |||
Price To Earnings To Growth | (0.02) X | |||
Target Price | 3.1 | |||
Number Of Employees | 268 | |||
Beta | 1.7 | |||
Market Capitalization | 127.83 M | |||
Total Asset | 172.54 M | |||
Retained Earnings | (930.45 M) | |||
Working Capital | 99.45 M | |||
Current Asset | 127.46 M | |||
Current Liabilities | 21.75 M | |||
Z Score | -6.55 | |||
Net Asset | 172.54 M |
About Paratek Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Paratek Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Paratek Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Paratek Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in Paratek Stock
If you are still planning to invest in Paratek Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paratek Pharmaceuticals' history and understand the potential risks before investing.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |